What is M1 Kliniken AG (MKLNF)?

M1 Kliniken AG (MKLNF) is a stock in the Healthcare sector, Medical - Care Facilities industry. View full analysis on Stocks360.

What is the current price of MKLNF?

The current price of MKLNF is $11.73. Prices are updated in real time on Stocks360.

What is MKLNF's price-to-earnings (PE) ratio?

MKLNF's trailing twelve-month PE ratio is 9.74, based on current price and earnings per share data available on Stocks360.

What is MKLNF's market capitalization?

MKLNF's market capitalization is $214,805,646.00, placing it in the small-cap tier.

Does MKLNF pay a dividend?

Yes. MKLNF has a trailing twelve-month dividend yield of 0.12%. Dividend data is sourced from financial market providers and displayed on Stocks360.

M1 Kliniken AG (MKLNF)

Stock analysis · OTC · Healthcare · Medical - Care Facilities

$11.73

Market Cap

$214.81M

PE (TTM)

9.74

EPS (TTM)

N/A

Dividend Yield

11.70%

Beta

1.14

Day Range

$11.73 – $11.73

52-wk Range

$11.73 – $11.73

Avg Volume

N/A

Volume

1.65K

M1 Kliniken AG (MKLNF) is a publicly traded company in the Healthcare sector. Latest price: $11.73. Market cap $214.81M. Trailing PE 9.74. Dividend yield 11.70%. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

1-Year Price

2025-10-29 · $11.73 2026-04-06 · $11.73 (+0.00%)

Earnings

Most Recent

Aug 26, 2020

EPS $0.13 vs est. $0.13

Beat by $0.00

Proprietary Signals

Signal snapshot temporarily unavailable.

About M1 Kliniken AG

M1 Kliniken AG, along with its affiliated entities, delivers aesthetic and plastic surgery services through a network of medical facilities spanning Germany, Austria, the Netherlands, Switzerland, the United Kingdom, Croatia, and Australia. The company structures its operations into two core divisions: Beauty and Trade. Under its Beauty segment, M1 develops and commercializes a range of pharmaceutical, medical, and medical technology products designed for aesthetic medicine and cosmetic dermatology. These products are distributed to healthcare professionals, pharmacies, and wholesalers under the "M1 Select" brand. The Trade segment focuses on the broad commercial distribution of diverse medical products, including pharmaceuticals, biosimilars, and various medical devices. This trading activity covers critical therapeutic areas such as oncology, HIV treatment, rheumatology, neurology, cardiovascular diseases, and controlled substances. Furthermore, the company is involved in real estate, specifically the acquisition, management, and sale of properties, with a predominant focus on the healthcare sector. M1 Kliniken AG's service infrastructure includes a specialized surgical clinic a…

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	9.74×
P/S (TTM)	0.75×
P/B	1.59×
PEG	0.78×
P/FCF (TTM)	8.37×
EV / EBITDA	3.78×
EV / Sales	0.54×
Earnings Yield	10.25%
Free Cash Flow Yield	11.95%
Dividend Yield	11.70%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$138.09M
Revenue (TTM)	$256.70M
Net Income (TTM)	$19.74M
Free Cash Flow (TTM)	$23.66M
Net Debt	-$54.51M
Working Capital	$86.60M
Gross Margin	18.50%
Operating Margin	12.51%
Net Margin	7.85%
Return on Equity	16.53%
Return on Invested Capital	13.75%